©istock.com/Andrea Obzerova
Interdisziplinäre KompetenzMolekulare Diagnostik
Know how bei der Analyse von Erbmaterial.
Zum Wohle von Patienten.

ErkrankungHypophysenhormon-Defizienz, Differentialdiagnose

Zusammenfassung

Kurzinformation

Umfassendes differentialdiagnostisches panel für Hypophysenhormon-Defizienz, Differentialdiagnose, mit 18 bzw. insgesamt 45 kuratierten Genen gemäß klinischer Verdachtsdiagnose

ID
HP1250
Anzahl Gene
44 Akkreditierte Untersuchung
Untersuchte Sequenzlänge
23,3 kb (Core-/Basis-Gene)
97,2 kb (Erweitertes Panel)
Analyse-Dauer
auf Anfrage
Material
  • EDTA-Blut (3-5 ml)
Diagnostische Hinweise

NGS +

[Sanger]

 

Genpanel

Ausgewählte Gene

NameExon-Länge (bp)OMIM-GErbgang
FGF8735AD
FOXA21392AD
GH1654AD und/oder AR
GHR1917AD und/oder AR
GHRHR1272AR
GHSR1101AD und/oder AR
GLI24761AD
GNRHR987AR und/oder Dig
HESX1558AD und/oder AR
LHX31209AR
LHX41173AD
OTX2870AD
POU1F1876AD und/oder AR
PROP1681AR
SHH1389AD und/oder Dig
SOX2954AD
SOX31341XL
TBX191347AR
ARNT22154AR
BTK1980XLR und/oder SMu
CDON3795AD
CHD78994AD und/oder Impr
DISP14575AD und/oder Dig
DLL12172AD
FGFR12469AD und/oder Dig
FOXC11662AD und/oder Dig und/oder SMu und/oder Sus
FOXH11098AD
GLI34743AD
IGSF14026XLR
KCNQ12031AD und/oder AR und/oder Dig und/oder Sus
NFKB22703AD
NODAL1044AD
PITX2816AD und/oder Dig und/oder Sus
PNPLA63984AR
PROKR21155AD und/oder Dig
PTCH14344AD und/oder SMu
RBM282280AR
SIX3999AD und/oder AR
SMC1A3702XLD und/oder Impr
STAG23807XL und/oder SMu
TCF7L11767AD
TGIF1819AD
UBR15250AR
ZIC21599AD

Infos zur Erkrankung

Klinischer Kommentar

Der Hypophysenvorderlappen produziert und sezerniert spezifische Hormone wie Wachstumshormon (GH), Prolactin (PRL), Thyroidea-stimulierendes Hormon (TSH), Luteinisierendes Hormon (LH), Follikel-stimulierendes Hormon (FSH) und Adrenocorticotropische Hormon (ACTH). Insbesondere früh wirkende Faktoren, die sich an der Hypophysen-Organogenese beteiligen, sind nicht Hypophysen-spezifisch, sondern werden auch für die Entwicklung anderer Organe und Strukturen benötigt. Läsionen in diesen Genen können auch Defekte in der Entwicklung von kraniofazialen, sensorischen oder vielen anderen Strukturen verursachen. Stattdessen sind Faktoren, die später in der Spezifikation der hypophysären Zelllinien wirken, eher spezifisch für jeden Zelltyp, aber nicht unbedingt auf die sich entwickelnde oder reife Hypophyse beschränkt. Eine gestörte Expression oder Funktion dieser Faktoren verursacht Störungen in der Hypophyse und führt schließlich zur defizienten Sekretion von Hypophysen-Hormonen. Daher umfasst dieses panel viele Gene, deren Malfunktion zu einer sehr breiten klinischen Symptompalette führen kann. Es werden alle monogenen und auch multifaktorielle Erbgänge beobachtet. In 20–30% der familiären Fälle werden vollständig penetrante Mutationen in bekannten Genen identifiziert. Die DNA-diagnostische Ausbeute ist jedoch derzeit insgesamt nicht bekannt, sodass eine klinische Diagnose durch ein negatives molekulargenetisches Ergebnis keinesfalls ausgeschlossen werden kann.

Referenzen: https://www.ncbi.nlm.nih.gov/books/NBK1347/

https://www.ncbi.nlm.nih.gov/books/NBK97965https://www.ncbi.nlm.nih.gov/books/NBK1334//

https://www.ncbi.nlm.nih.gov/books/NBK476671/

 

Synonyme
  • Allelic: Mitochondrial complex II deficiency, nuclear type 1 (SDHA)
  • Alias: Combined pituitary hormone deficiency, included
  • Alias: Congenital combined pituitary hormone deficiency, included
  • Alias: Congenital hypopituitarism, included
  • Alleic: Atrial fibrillation, familial, 3 (KCNQ1)
  • Alleic: Long QT syndrome 1 (KCNQ1)
  • Allelic. Cardiomyopathy, dilated, 1GG (SDHA)
  • Allelic. Mitochondrial complex II deficiency, nuclear type 4 (SDHB)
  • Allelic: Agammaglobulinemia, X-linked 1 (BTK)
  • Allelic: Anterior segment dysgenesis 4 (PITX2)
  • Allelic: Axenfeld-Rieger syndrome, type 1 (PITX2)
  • Allelic: Basal cell carcinoma, somatic (PTCH1)
  • Allelic: Basal cell nevus syndrome (PTCH1)
  • Allelic: Carcinoid tumor of lung (MEN1)
  • Allelic: Colorectal cancer, hereditary nonpolyposis, type 1 (MSH2)
  • Allelic: Colorectal cancer, hereditary nonpolyposis, type 2 (MLH1)
  • Allelic: Colorectal cancer, hereditary nonpolyposis, type 4 (PMS2)
  • Allelic: Colorectal cancer, hereditary nonpolyposis, type 5 (MSH6)
  • Allelic: Encephalocraniocutaneous lipomatosis, somatic mosaic (FGFR1)
  • Allelic: Endometrial cancer, familial (MSH6)
  • Allelic: Gastrointestinal stromal tumor (SDHB, SDHC)
  • Allelic: Greig cephalopolysyndactyly syndrome (GLI3)
  • Allelic: Hartsfield syndrome (FGFR1)
  • Allelic: Hirschsprung disease, protection against (RET)
  • Allelic: Hirschsprung disease, susceptibility to, 1 (RET)
  • Allelic: Holoprosencephaly 3 (SHH)
  • Allelic: Holoprosencephaly 9 (GLI2)
  • Allelic: Hypercholesterolemia, familial, modifier of (GHR)
  • Allelic: Increased responsiveness to growth hormone (GHR)
  • Allelic: Jackson-Weiss syndrome (FGFR1)
  • Allelic: Kowarski syndrome (GH1)
  • Allelic: Laron dwarfism (GHR)
  • Allelic: Long QT syndrome 1, acquired, susceptibility to (KCNQ1)
  • Allelic: Medullary thyroid carcinoma (RET)
  • Allelic: Mental retardation, XL, with isolated growth hormone deficiency (SOX3)
  • Allelic: Microphthalmia with coloboma 5 (SHH)
  • Allelic: Microphthalmia, syndromic 3 (SOX2)
  • Allelic: Microphthalmia, syndromic 5 (OTX2)
  • Allelic: Mitochondrial complex II deficiency, nuclear type 3 (SDHD)
  • Allelic: Muir-Torre syndrome (MLH1, MSH2)
  • Allelic: Myxoma, intracardiac (PRKAR1A)
  • Allelic: Neurodegeneration with ataxia + late-onset optic atrophy (SDHA)
  • Allelic: Optic nerve hypoplasia + abnormalities of the central nervous system (SOX2)
  • Allelic: Osteoglophonic dysplasia (FGFR1)
  • Allelic: PCWH syndrome (SOX10)
  • Allelic: Pfeiffer syndrome (FGFR1)
  • Allelic: Pleuropulmonary blastoma (DICER1)
  • Allelic: Polydactyly, postaxial, types A1 + B (GLI3)
  • Allelic: Polydactyly, preaxial, type IV (GLI3)
  • Allelic: Precocious puberty, central, 1 (KISS1R)
  • Allelic: Retinal dystrophy, early-onset, with/-out pituitary dysfunction (OTX2)
  • Allelic: Rhabdomyosarcoma, embryonal, 2 (DICER1)
  • Allelic: Ring dermoid of cornea (PITX2)
  • Allelic: Schizencephaly (SHH, SIX3)
  • Allelic: Septooptic dysplasia (HESX1)
  • Allelic: Short QT syndrome 2 (KCNQ1)
  • Allelic: Single median maxillary central incisor (SHH)
  • Allelic: Spastic paraplegia 39, AR (PNPLA6)
  • Allelic: Trigonocephaly (FGFR1)
  • Allelic: Waardenburg syndrome, type 4C (SOX10)
  • ACTH-independent macronodular adrenal hyperplasia (GNAS)
  • Acrodysostosis 1, with/-out hormone resistance (PRKAR1A)
  • Adrenocorticotropic hormone deficiency (TBX19)
  • Alopecia, neurologic defects + endocrinopathy syndrome (RBM28)
  • Boucher-Neuhauser syndrome (PNPLA6)
  • Brain, CNS + PNS cancer [panelapp] (MLH1, MSH2, MSH6)
  • CHARGE syndrome (CHD7)
  • CHARGE syndrome (SEMA3E)
  • Cardioacrofacial dysplasia 2 (PRKACB)
  • Carney complex, type 1 (PRKAR1A)
  • Charcot-Marie-Tooth disease, demyelinating, type 1I (POLR3B)
  • Congenital complex pituitary hormone deficiency (FOXA2)
  • Cornelia de Lange syndrome 2 (SMC1A)
  • Culler-Jones syndrome (GLI2)
  • Developmental + epileptic encephalopathy 85, with/-out midline brain defects (SMC1A)
  • Encephalocraniocutaneous lipomatosis, somatic mosaic (FGFR1)
  • Goiter, multinodular 1, with/-out Sertoli-Leydig cell tumors (DICER1)
  • Growth hormone deficiency with pituitary anomalies (HESX1)
  • Growth hormone deficiency, isolated partial (GHSR)
  • Growth hormone deficiency, isolated, type IA, IB, II (GH1)
  • Growth hormone deficiency, isolated, type IV (GHRHR)
  • Growth hormone insensitivity, partial (GHR)
  • Heterotaxy, visceral, 5 (NODAL)
  • Holoprosencephaly (DISP1)
  • Holoprosencephaly 11 (CDON)
  • Holoprosencephaly 13, XL (STAG2)
  • Holoprosencephaly 2 (SIX3)
  • Holoprosencephaly 3 (SHH)
  • Holoprosencephaly 4 (TGIF1)
  • Holoprosencephaly 5 (ZIC2)
  • Holoprosencephaly 7 (PTCH1)
  • Holoprosencephaly [A-/Lobar, Microform, Midline interhemispheric v., Semilobar, Septooptic] (FOXH1)
  • Holoprosencephaly [A-/Lobar, Microform, Midline interhemispheric var., Semilobar, Septooptic] (GAS1)
  • Hypogonadotropic hypogonadism 1 with/-out anosmia, Kallmann syndrome 1 (ANOS1)
  • Hypogonadotropic hypogonadism 10 with-out anosmia (TAC3)
  • Hypogonadotropic hypogonadism 11 with/-out anosmia (TACR3)
  • Hypogonadotropic hypogonadism 12 with/-out anosmia (GNRH1)
  • Hypogonadotropic hypogonadism 13 with/-out anosmia (KISS1)
  • Hypogonadotropic hypogonadism 14 with/-out anosmia (WDR11)
  • Hypogonadotropic hypogonadism 15 with/-out anosmia (HS6ST1)
  • Hypogonadotropic hypogonadism 16 with/-out anosmia (SEMA3A)
  • Hypogonadotropic hypogonadism 17 with/-out anosmia (SPRY4)
  • Hypogonadotropic hypogonadism 18 with/-out anosmia (IL17RD)
  • Hypogonadotropic hypogonadism 19 with/-out anosmia (DUSP6)
  • Hypogonadotropic hypogonadism 2 with/-out anosmia (FGFR1)
  • Hypogonadotropic hypogonadism 20 with/-out anosmia (FGF17)
  • Hypogonadotropic hypogonadism 21 with anosmia (FLRT3)
  • Hypogonadotropic hypogonadism 22, with/-out anosmia (FEZF1)
  • Hypogonadotropic hypogonadism 3 with/-out anosmia (PROKR2)
  • Hypogonadotropic hypogonadism 4 with/-out anosmia (PROK2)
  • Hypogonadotropic hypogonadism 5 with/-out anosmia (CHD7)
  • Hypogonadotropic hypogonadism 6 with/-out anosmia (FGF8)
  • Hypogonadotropic hypogonadism 7 without anosmia (GNRHR)
  • Hypogonadotropic hypogonadism 8 with/-out anosmia (KISS1R)
  • Hypogonadotropic hypogonadism 9 with/-out anosmia (NSMF)
  • Hypogonadotropic hypogonadism [Lit.] (AXL)
  • Hypogonadotropic hypogonadism [panelapp] (IGSF10)
  • Hypothyroidism, central + testicular enlargement (IGSF1)
  • Immunodeficiency, common variable, 10 (NFKB2)
  • Isolated GnRH hormone deficiency (CCDC14)
  • Isolated gonadotropin-releasing hormone deficiency [] genereview (SRA1)
  • Isolated growth hormone deficiency, type III, with agammaglobulinemia (BTK)
  • Jervell and Lange-Nielsen syndrome (KCNQ1)
  • Johanson-Blizzard syndrome (UBR1)
  • Laurence-Moon syndrome (PNPLA6)
  • Leukodystrophy, hypomyelinating, 8, with/-out oligodontia +/- hypogonadotropic hypogonadism (POLR3B)
  • McCune-Albright syndrome, somatic, mosaic (GNAS)
  • Mismatch repair cancer syndrome 1 (MLH1)
  • Mismatch repair cancer syndrome 2 (MSH2)
  • Mismatch repair cancer syndrome 3 (MSH6)
  • Mismatch repair cancer syndrome 4 (PMS2)
  • Mullegama-Klein-Martinez syndrome (STAG2)
  • Multiple endocrine neoplasia 1 (MEN1)
  • Multiple endocrine neoplasia 1 [panelapp] (CDKN1A)
  • Multiple endocrine neoplasia 1 [panelapp] (CDKN2B)
  • Multiple endocrine neoplasia 1 [panelapp] (CDKN2C)
  • Multiple endocrine neoplasia IIA + IIB (RET)
  • Neurodevelopmental disorder with nonspecific brain abnormalities, with/-out seizures (DLL1)
  • Oliver-McFarlane syndrome (PNPLA6)
  • Optic nerve hypoplasia and abnormalities of the CNS (SOX2)
  • Osseous heteroplasia, progressive (GNAS)
  • Pallister-Hall syndrome (GLI3)
  • Panhypopituitarism, XL (SOX3)
  • Paraganglioma + gastric stromal sarcoma (SDHB, SDHC, SDHD)
  • Paragangliomas 1, with/-out deafness (SDHD)
  • Paragangliomas 3 (SDHC)
  • Paragangliomas 4 (SDHB)
  • Paragangliomas 5 (SDHA)
  • Pheochromocytoma (RET, SDHB, SDHD)
  • Pheochromocytoma, susceptibility to (MAX)
  • Pigmented nodular adrenocortical disease, primary, 1 (PRKAR1A)
  • Pituitary adenoma 1, multiple types (AIP)
  • Pituitary adenoma 2, GH-secreting (GPR101)
  • Pituitary adenoma 3, multiple types, somatic (GNAS)
  • Pituitary adenoma 4, ACTH-secreting, somatic (USP8)
  • Pituitary adenoma predisposition (AIP)
  • Pituitary hormone deficiency (KCNQ1)
  • Pituitary hormone deficiency (TCF7L1)
  • Pituitary hormone deficiency, combined, 1 (POU1F1)
  • Pituitary hormone deficiency, combined, 2 (PROP1)
  • Pituitary hormone deficiency, combined, 3 (LHX3)
  • Pituitary hormone deficiency, combined, 4 (LHX4)
  • Pituitary hormone deficiency, combined, 5 (HESX1)
  • Pituitary hormone deficiency, combined, 6 (OTX2)
  • Pseudohypoparathyroidism Ia, Ib, Ic (GNAS)
  • Pseudopseudohypoparathyroidism (GNAS)
  • Retinal dystrophy, early-onset, with/-out pituitary dysfunction (OTX2)
  • Waardenburg syndrome, type 2E, with/-out neurologic involvement (SOX10)
  • Webb-Dattani syndrome (ARNT2)
Erbgänge, Vererbungsmuster etc.
  • AD
  • AD und/oder AR
  • AD und/oder AR und/oder Dig und/oder Sus
  • AD und/oder Dig
  • AD und/oder Dig und/oder SMu und/oder Sus
  • AD und/oder Dig und/oder Sus
  • AD und/oder Impr
  • AD und/oder SMu
  • AR
  • AR und/oder Dig
  • XL
  • XL und/oder SMu
  • XLD und/oder Impr
  • XLR
  • XLR und/oder SMu
OMIM-Ps
  • Multiple OMIM-Ps
ICD10 Code
E23.-

Bioinformatik und klinische Interpretation

Kein Text hinterlegt